Covidien reaches $3.5M settlement with Rochester Medical

Covidien has reached a $3.5 million settlement in litigation that Rochester Medical filed on March 16, 2004 against CR Bard; Tyco International and Healthcare Group (now Covidien); Novation; VHA; and Premier Purchasing Partners.

The Stewartville, Minn.-based company has previously won settlements with all other co-defendants. Bard settled for $49 million and Premier settled for more than $8.8 million.

Under the terms of the settlement, Rochester Medical, represented by the Lanier Law Firm and Patton, Tidwell & Schroeder, dismissed Covidien from the litigation with prejudice. Covidien will pay out a total of $3.5 million, out of which Rochester Medical will pay approximately $2.5 million in attorney's fees and expenses. The company said that the impact of the settlement will be reflected in its second quarter financials. 

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.